TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs3771317
log Bayes Factor = 0.195121
Chromosome 2   position 191,543,962  (GRCh37) Explore rs3771317 on Ensembl!
Variant rs3771317 is listed in the   GWAS Catalog   ⇪

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)
Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
T36-T50 Poisoning by drugs, medicaments and biological substances
0.000 0.658 0.342
T43 Poisoning by psychotropic drugs, not elsewhere classified
0.000 0.662 0.338
T43.0 Tricyclic and tetracyclic antidepressants
0.000 0.676 0.324
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs
0.000 0.677 0.323
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances
0.000 0.678 0.322
T46 Poisoning by agents primarily affecting the cardiovascular system
0.000 0.683 0.317
T50.9 Other and unspecified drugs, medicaments and biological substances
0.000 0.692 0.308
T43.5 Other and unspecified antipsychotics and neuroleptics
0.000 0.709 0.291
T42.4 Benzodiazepines
0.000 0.710 0.290
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics
0.000 0.712 0.288
T47 Poisoning by agents primarily affecting gastro-intestinal system
0.000 0.717 0.283
T43.2 Other and unspecified antidepressants
0.000 0.717 0.283
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]
0.000 0.721 0.279
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs
0.000 0.722 0.278
T42.6 Other antiepileptic and sedative-hypnotic drugs
0.000 0.728 0.272
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]
0.000 0.735 0.265
T43.3 Phenothiazine antipsychotics and neuroleptics
0.000 0.736 0.263
T46.4 Angiotensin-converting-enzyme inhibitors
0.000 0.738 0.262
T46.1 Calcium-channel blockers
0.000 0.739 0.261
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified
0.000 0.740 0.260
T42.1 Iminostilbenes
0.000 0.741 0.259
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified
0.000 0.751 0.249
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs
0.000 0.755 0.245
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system
0.000 0.755 0.245
T41 Poisoning by anaesthetics and therapeutic gases
0.000 0.755 0.245
T37 Poisoning by other systemic anti-infectives and antiparasitics
0.000 0.755 0.245
T43.9 Psychotropic drug, unspecified
0.000 0.758 0.242
T43.8 Other psychotropic drugs, not elsewhere classified
0.000 0.758 0.242
T43.4 Butyrophenone and thioxanthene neuroleptics
0.000 0.758 0.242
T43.1 Monoamine-oxidase-inhibitor antidepressants
0.000 0.758 0.242
T47.1 Other antacids and anti-gastric-secretion drugs
0.000 0.759 0.241
T36 Poisoning by systemic antibiotics
0.000 0.759 0.241
T44 Poisoning by drugs primarily affecting the autonomic nervous system
0.000 0.761 0.239
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants
0.000 0.768 0.232
T42.5 Mixed antiepileptics, not elsewhere classified
0.000 0.768 0.232
T42.3 Barbiturates
0.000 0.768 0.232
T42.2 Succinimides and oxazolidinediones
0.000 0.768 0.232
T50.8 Diagnostic agents
0.000 0.769 0.231
T50.7 Analeptics and opioid receptor antagonists
0.000 0.769 0.231
T50.6 Antidotes and chelating agents, not elsewhere classified
0.000 0.769 0.231
T50.5 Appetite depressants
0.000 0.769 0.231
T50.4 Drugs affecting uric acid metabolism
0.000 0.769 0.231
T50.3 Electrolytic, caloric and water-balance agents
0.000 0.769 0.231
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics
0.000 0.769 0.231
T50.1 Loop [high-ceiling] diuretics
0.000 0.769 0.231
T50.0 Mineralocorticoids and their antagonists
0.000 0.769 0.231
T40.2 Other opioids
0.000 0.771 0.229
T46.9 Other and unspecified agents primarily affecting the cardiovascular system
0.000 0.772 0.228
T46.8 Antivaricose drugs, including sclerosing agents
0.000 0.772 0.228
T46.7 Peripheral vasodilators
0.000 0.772 0.228
T46.5 Other antihypertensive drugs, not elsewhere classified
0.000 0.772 0.228
T46.2 Other antidysrhythmic drugs, not elsewhere classified
0.000 0.772 0.228
T46.0 Cardiac-stimulant glycosides and drugs of similar action
0.000 0.772 0.228
T45.0 Antiallergic and antiemetic drugs
0.000 0.774 0.226
T40.6 Other and unspecified narcotics
0.000 0.781 0.219
T39.1 4-Aminophenol derivatives
0.000 0.788 0.212
T46.3 Coronary vasodilators, not elsewhere classified
0.000 0.789 0.210
T42.0 Hydantoin derivatives
0.000 0.791 0.209
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified
0.000 0.794 0.206
T39.4 Antirheumatics, not elsewhere classified
0.000 0.794 0.206
T39.2 Pyrazolone derivatives
0.000 0.794 0.206
T43.6 Psychostimulants with abuse potential
0.000 0.796 0.203
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified
0.000 0.797 0.203
T47.8 Other agents primarily affecting the gastro-intestinal system
0.000 0.797 0.203
T47.7 Emetics
0.000 0.797 0.203
T47.6 Antidiarrhoeal drugs
0.000 0.797 0.203
T47.5 Digestants
0.000 0.797 0.203
T47.4 Other laxatives
0.000 0.797 0.203
T47.3 Saline and osmotic laxatives
0.000 0.797 0.203
T47.2 Stimulant laxatives
0.000 0.797 0.203
T47.0 Histamine H(2)-receptor antagonists
0.000 0.797 0.203
T40.9 Other and unspecified psychodysleptics [hallucinogens]
0.000 0.800 0.200
T40.8 Lysergide [LSD]
0.000 0.800 0.200
T40.7 Cannabis (derivatives)
0.000 0.800 0.200
T40.5 Cocaine
0.000 0.800 0.200
T40.3 Methadone
0.000 0.800 0.200
T40.1 Heroin
0.000 0.800 0.200
T40.0 Opium
0.000 0.800 0.200
T45.5 Anticoagulants
0.000 0.812 0.188
T45.9 Primarily systemic and haematological agent, unspecified
0.000 0.813 0.186
T45.8 Other primarily systemic and haematological agents
0.000 0.813 0.186
T45.7 Anticoagulant antagonists, vitamin K and other coagulants
0.000 0.813 0.186
T45.6 Fibrinolysis-affecting drugs
0.000 0.813 0.186
T45.4 Iron and its compounds
0.000 0.813 0.186
T45.3 Enzymes, not elsewhere classified
0.000 0.813 0.186
T40.4 Other synthetic narcotics
0.000 0.814 0.186
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified
0.000 0.819 0.181
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified
0.000 0.821 0.179
T37.9 Systemic anti-infective and antiparasitic, unspecified
0.000 0.824 0.176
T37.8 Other specified systemic anti-infectives and antiparasitics
0.000 0.824 0.176
T37.5 Antiviral drugs
0.000 0.824 0.176
T37.4 Anthelminthics
0.000 0.824 0.176
T37.3 Other antiprotozoal drugs
0.000 0.824 0.176
T37.2 Antimalarials and drugs acting on other blood protozoa
0.000 0.824 0.176
T37.1 Antimycobacterial drugs
0.000 0.824 0.176
T37.0 Sulphonamides
0.000 0.824 0.176
T41.5 Therapeutic gases
0.000 0.824 0.176
T41.4 Anaesthetic, unspecified
0.000 0.824 0.176
T41.3 Local anaesthetics
0.000 0.824 0.176
T41.2 Other and unspecified general anaesthetics
0.000 0.824 0.176
T41.1 Intravenous anaesthetics
0.000 0.824 0.176
T41.0 Inhaled anaesthetics
0.000 0.824 0.176
T48.7 Other and unspecified agents primarily acting on the respiratory system
0.000 0.824 0.176
T48.6 Antiasthmatics, not elsewhere classified
0.000 0.824 0.176
T48.5 Anti-common-cold drugs
0.000 0.824 0.176
T48.4 Expectorants
0.000 0.824 0.176
T48.3 Antitussives
0.000 0.824 0.176
T48.2 Other and unspecified agents primarily acting on muscles
0.000 0.824 0.176
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]
0.000 0.824 0.176
T48.0 Oxytocic drugs
0.000 0.824 0.176
T49.9 Topical agent, unspecified
0.000 0.824 0.176
T49.8 Other topical agents
0.000 0.824 0.176
T49.7 Dental drugs, topically applied
0.000 0.824 0.176
T49.6 Otorhinolaryngological drugs and preparations
0.000 0.824 0.176
T49.5 Ophthalmological drugs and preparations
0.000 0.824 0.176
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations
0.000 0.824 0.176
T49.3 Emollients, demulcents and protectants
0.000 0.824 0.176
T49.2 Local astringents and local detergents
0.000 0.824 0.176
T49.1 Antipruritics
0.000 0.824 0.176
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified
0.000 0.824 0.176
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.000 0.827 0.173
T39.0 Salicylates
0.000 0.827 0.173
T36.9 Systemic antibiotic, unspecified
0.000 0.827 0.173
T36.8 Other systemic antibiotics
0.000 0.827 0.173
T36.7 Antifungal antibiotics, systemically used
0.000 0.827 0.173
T36.6 Rifamycins
0.000 0.827 0.173
T36.5 Aminoglycosides
0.000 0.827 0.173
T36.4 Tetracyclines
0.000 0.827 0.173
T36.3 Macrolides
0.000 0.827 0.173
T36.2 Chloramphenicol group
0.000 0.827 0.173
T36.1 Cefalosporins and other Beta-lactam antibiotics
0.000 0.827 0.173
T44.9 Other and unspecified drugs primarily affecting the nervous system
0.000 0.829 0.171
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified
0.000 0.829 0.171
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified
0.000 0.829 0.171
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified
0.000 0.829 0.171
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified
0.000 0.829 0.171
T44.2 Ganglionic blocking drugs, not elsewhere classified
0.000 0.829 0.171
T44.1 Other parasympathomimetics [cholinergics]
0.000 0.829 0.171
T44.0 Anticholinesterase agents
0.000 0.829 0.171
T36.0 Penicillins
0.000 0.832 0.168
T45.1 Antineoplastic and immunosuppressive drugs
0.000 0.833 0.166
T45.2 Vitamins, not elsewhere classified
0.000 0.841 0.159
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified
0.000 0.845 0.155
T38.9 Other and unspecified hormone antagonists
0.000 0.875 0.124
T38.8 Other and unspecified hormones and their synthetic substitutes
0.000 0.875 0.124
T38.7 Androgens and anabolic congeners
0.000 0.875 0.124
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified
0.000 0.875 0.124
T38.5 Other oestrogens and progestogens
0.000 0.875 0.124
T38.4 Oral contraceptives
0.000 0.875 0.124
T38.2 Antithyroid drugs
0.000 0.875 0.124
T38.0 Glucocorticoids and synthetic analogues
0.000 0.875 0.124
T38.1 Thyroid hormones and substitutes
0.001 0.884 0.116
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs
0.001 0.930 0.070
C85 Other and unspecified types of non-Hodgkin's lymphoma
0.070 0.930 0.000
C85.1 B-cell lymphoma, unspecified
0.070 0.930 0.000
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue
0.065 0.935 0.000
C85.9 Non-Hodgkin's lymphoma, unspecified type
0.064 0.936 0.000
C81 Hodgkin's disease
0.062 0.938 0.000
C83 Diffuse non-Hodgkin's lymphoma
0.060 0.940 0.000
C82 Follicular [nodular] non-Hodgkin's lymphoma
0.058 0.942 0.000
C83.3 Large cell (diffuse)
0.057 0.943 0.000
C85.7 Other specified types of non-Hodgkin's lymphoma
0.057 0.943 0.000
C81.1 Nodular sclerosis
0.056 0.944 0.000
C81.9 Hodgkin's disease, unspecified
0.055 0.945 0.000
C90 Multiple myeloma and malignant plasma cell neoplasms
0.053 0.947 0.000
C83.0 Small cell (diffuse)
0.052 0.948 0.000
C85.2 Mediastinal (thymic) large B-cell lymphoma
0.050 0.949 0.000
C85.0 Lymphosarcoma
0.050 0.949 0.000
C95 Leukaemia of unspecified cell type
0.048 0.952 0.000
C82.2 Large cell, follicular
0.048 0.952 0.000
C82.9 Follicular non-Hodgkin's lymphoma, unspecified
0.048 0.952 0.000
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue
0.047 0.953 0.000
C94 Other leukaemias of specified cell type
0.047 0.953 0.000
C93 Monocytic leukaemia
0.047 0.953 0.000
C86 Other specified types of T/NK-cell lymphoma
0.047 0.953 0.000
C88 Malignant immunoproliferative diseases
0.047 0.953 0.000
C90.2 Plasmacytoma, extramedullary
0.047 0.953 0.000
C90.3 Solitary plasmacytoma
0.045 0.955 0.000
C83.7 Burkitt's tumour
0.045 0.955 0.000
C81.7 Other Hodgkin's disease
0.044 0.955 0.000
C81.4 Lymphocyte-rich classical Hodgkin lymphoma
0.044 0.955 0.000
C81.3 Lymphocytic depletion
0.044 0.955 0.000
C81.2 Mixed cellularity
0.044 0.955 0.000
C81.0 Lymphocytic predominance
0.044 0.955 0.000
C83.6 Undifferentiated (diffuse)
0.043 0.957 0.000
C83.5 Lymphoblastic (diffuse)
0.043 0.957 0.000
C83.4 Immunoblastic (diffuse)
0.043 0.957 0.000
C83.2 Mixed small and large cell (diffuse)
0.043 0.957 0.000
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified
0.043 0.957 0.000
C82.0 Small cleaved cell, follicular
0.043 0.957 0.000
C82.7 Other types of follicular non-Hodgkin's lymphoma
0.043 0.957 0.000
C82.1 Mixed small cleaved and large cell, follicular
0.042 0.958 0.000
C82.6 Cutaneous follicle centre lymphoma
0.041 0.958 0.000
C82.5 Diffuse follicle centre lymphoma
0.041 0.958 0.000
C82.4 Follicular lymphoma grade IIIb
0.041 0.958 0.000
C82.3 Follicular lymphoma grade IIIa
0.041 0.958 0.000
C84 Peripheral and cutaneous T-cell lymphomas
0.040 0.960 0.000
C91 Lymphoid leukaemia
0.039 0.961 0.000
C83.1 Small cleaved cell (diffuse)
0.038 0.961 0.000
C90.1 Plasma cell leukaemia
0.038 0.961 0.000
C95.9 Leukaemia, unspecified
0.036 0.964 0.000
C95.7 Other leukaemia of unspecified cell type
0.035 0.965 0.000
C95.2 Subacute leukaemia of unspecified cell type
0.035 0.965 0.000
C95.1 Chronic leukaemia of unspecified cell type
0.035 0.965 0.000
C95.0 Acute leukaemia of unspecified cell type
0.035 0.965 0.000
C88.0 Waldenstrom's macroglobulinaemia
0.034 0.965 0.000
C86.6 Primary cutaneous CD30-positive T-cell proliferations
0.034 0.966 0.000
C86.5 Angioimmunoblastic T-cell lymphoma
0.034 0.966 0.000
C86.4 Blastic NK-cell lymphoma
0.034 0.966 0.000
C86.3 Subcutaneous panniculitis-like T-cell lymphoma
0.034 0.966 0.000
C86.2 Enteropathy-type (intestinal) T-cell lymphoma
0.034 0.966 0.000
C86.1 Hepatosplenic T-cell lymphoma
0.034 0.966 0.000
C86.0 Extranodal NK/T-cell lymphoma, nasal type
0.034 0.966 0.000
C93.9 Monocytic leukaemia, unspecified
0.034 0.966 0.000
C93.7 Other monocytic leukaemia
0.034 0.966 0.000
C93.3 Juvenile myelomonocytic leukaemia
0.034 0.966 0.000
C93.2 Subacute monocytic leukaemia
0.034 0.966 0.000
C93.1 Chronic monocytic leukaemia
0.034 0.966 0.000
C93.0 Acute monocytic leukaemia
0.034 0.966 0.000
C94.7 Other specified leukaemias
0.034 0.966 0.000
C94.6 Myelodysplastic and myeloproliferative disease, not elsewhere classified
0.034 0.966 0.000
C94.5 Acute myelofibrosis
0.034 0.966 0.000
C94.4 Acute panmyelosis
0.034 0.966 0.000
C94.3 Mast cell leukaemia
0.034 0.966 0.000
C94.2 Acute megakaryoblastic leukaemia
0.034 0.966 0.000
C94.1 Chronic erythraemia
0.034 0.966 0.000
C94.0 Acute erythraemia and erythroleukaemia
0.034 0.966 0.000
C96.9 Malignant neoplasms of lymphoid, haematopoietic and related tissue, unspecified
0.034 0.966 0.000
C96.8 Histiocytic sarcoma
0.034 0.966 0.000
C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue
0.034 0.966 0.000
C96.6 Unifocal Langerhans-cell histiocytosis
0.034 0.966 0.000
C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis
0.034 0.966 0.000
C96.4 Sarcoma of dendritic cells (accessory cells)
0.034 0.966 0.000
C96.3 True histiocytic lymphoma
0.034 0.966 0.000
C96.2 Malignant mast cell tumour
0.034 0.966 0.000
C96.1 Malignant histiocytosis
0.034 0.966 0.000
C96.0 Letterer-Siwe disease
0.034 0.966 0.000
C88.9 Malignant immunoproliferative disease, unspecified
0.034 0.966 0.000
C88.7 Other malignant immunoproliferative diseases
0.034 0.966 0.000
C88.3 Immunoproliferative small intestinal disease
0.034 0.966 0.000
C88.2 Gamma heavy chain disease
0.034 0.966 0.000
C88.1 Alpha heavy chain disease
0.034 0.966 0.000
C91.9 Lymphoid leukaemia, unspecified
0.033 0.967 0.000
C88.4 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]
0.033 0.967 0.000
C91.0 Acute lymphoblastic leukaemia
0.031 0.969 0.000
C84.9 Mature T/NK-cell lymphoma, unspecified
0.029 0.971 0.000
C84.8 Cutaneous T-cell lymphoma, unspecified
0.029 0.971 0.000
C84.7 Anaplastic large cell lymphoma, ALK-negative
0.029 0.971 0.000
C84.6 Anaplastic large cell lymphoma, ALK-positive
0.029 0.971 0.000
C84.3 Lymphoepithelioid lymphoma
0.029 0.971 0.000
C84.2 T-zone lymphoma
0.029 0.971 0.000
C84.1 Sezary's diease
0.029 0.971 0.000
C84.0 Mycosis fungoides
0.029 0.971 0.000
C91.8 Mature B-cell leukaemia Burkitt-type
0.028 0.972 0.000
C91.7 Other lymphoid leukaemia
0.028 0.972 0.000
C91.6 Prolymphocytic leukaemia of T-cell type
0.028 0.972 0.000
C91.5 Adult T-cell leukaemia
0.028 0.972 0.000
C91.3 Prolymphocytic leukaemia
0.028 0.972 0.000
C91.2 Subacute lymphocytic leukaemia
0.028 0.972 0.000
C50.3 Lower-inner quadrant of breast
0.028 0.972 0.000
C83.8 Other types of diffuse non-Hodgkin's lymphoma
0.027 0.973 0.000
C84.5 Other and unspecified T-cell lymphomas
0.026 0.974 0.000
C84.4 Peripheral T-cell lymphoma
0.026 0.974 0.000
C92 Myeloid leukaemia
0.023 0.976 0.001
C90.0 Multiple myeloma
0.022 0.978 0.000
C91.4 Hairy-cell leukaemia
0.021 0.979 0.000
F10.3 Withdrawal state
0.000 0.981 0.019
C92.4 Acute promyelocytic leukaemia
0.017 0.982 0.001
C92.9 Myeloid leukaemia, unspecified
0.017 0.983 0.001
C92.8 Acute myeloid leukaemia with multilineage dysplasia
0.017 0.983 0.001
C92.7 Other myeloid leukaemia
0.017 0.983 0.001
C92.6 Acute myeloid leukaemia with 11q23-abnormality
0.017 0.983 0.001
C92.5 Acute myelomonocytic leukaemia
0.017 0.983 0.001
C92.3 Myeloid sarcoma
0.017 0.983 0.001
C92.2 Subacute myeloid leukaemia
0.017 0.983 0.001
F10.2 Dependence syndrome
0.000 0.984 0.016
F10 Mental and behavioural disorders due to use of alcohol
0.000 0.985 0.015
C50 Malignant neoplasm of breast
0.014 0.986 0.000
N18.4 Chronic kidney disease, stage 4
0.014 0.986 0.000
C50.4 Upper-outer quadrant of breast
0.013 0.987 0.000
C50.1 Central portion of breast
0.013 0.987 0.000
F10.4 Withdrawal state with delirium
0.000 0.988 0.012
C92.1 Chronic myeloid leukaemia
0.012 0.988 0.001
F10.9 Unspecified mental and behavioural disorder
0.000 0.988 0.012
N19 Unspecified renal failure
0.011 0.989 0.000
C91.1 Chronic lymphocytic leukaemia
0.011 0.989 0.000
F10.8 Other mental and behavioural disorders
0.000 0.989 0.011
F10.7 Residual and late-onset psychotic disorder
0.000 0.989 0.011
F10.6 Amnesic syndrome
0.000 0.989 0.011
F10.5 Psychotic disorder
0.000 0.990 0.010
C50.6 Axillary tail of breast
0.010 0.990 0.000
C50.2 Upper-inner quadrant of breast
0.010 0.990 0.000
Z34.8 Supervision of other normal pregnancy
0.010 0.990 0.000
O68.0 Labour and delivery complicated by foetal heart rate anomaly
0.009 0.991 0.000
Y95 Nosocomial condition
0.009 0.991 0.000
C50.5 Lower-outer quadrant of breast
0.009 0.991 0.000
K60.1 Chronic anal fissure
0.008 0.992 0.000
N18 Chronic renal failure
0.008 0.992 0.000
T51.0 Ethanol
0.000 0.992 0.008
K60.0 Acute anal fissure
0.008 0.992 0.000
N17-N19 Renal failure
0.008 0.992 0.000
C50.8 Overlapping lesion of breast
0.007 0.993 0.000
N18.5 Chronic kidney disease, stage 5
0.007 0.993 0.000
N18.0 End-stage renal disease
0.007 0.993 0.000
K60 Fissure and fistula of anal and rectal regions
0.007 0.993 0.000
C50-C50 Malignant neoplasm of breast
0.007 0.993 0.000
F10-F19 Mental and behavioural disorders due to psychoactive substance use
0.000 0.993 0.007
K60.5 Anorectal fistula
0.007 0.993 0.000
F99 Mental disorder, not otherwise specified
0.000 0.994 0.006
N18.1 Chronic kidney disease, stage 1
0.006 0.994 0.000
M47.89 Other spondylosis (Site unspecified)
0.006 0.994 0.000
M79.60 Pain in limb (Multiple sites)
0.006 0.994 0.000
C92.0 Acute myeloid leukaemia
0.004 0.994 0.002
M25.46 Effusion of joint (Lower leg)
0.000 0.994 0.006
D69.3 Idiopathic thrombocytopenic purpura
0.006 0.994 0.000
F33.1 Recurrent depressive disorder, current episode moderate
0.000 0.994 0.006
M20.4 Other hammer toe(s) (acquired)
0.006 0.994 0.000
F99-F99 Unspecified mental disorder
0.000 0.994 0.006
I31.9 Disease of pericardium, unspecified
0.000 0.994 0.006
D69.6 Thrombocytopenia, unspecified
0.006 0.994 0.000
F33 Recurrent depressive disorder
0.000 0.994 0.006
F30-F39 Mood [affective] disorders
0.000 0.995 0.005
N18.8 Other chronic renal failure
0.005 0.995 0.000
M24.16 Other articular cartilage disorders (Lower leg)
0.000 0.995 0.005
C50.0 Nipple and areola
0.005 0.995 0.001
F33.2 Recurrent depressive disorder, current episode severe without psychotic symptoms
0.000 0.995 0.005
Chapter V Mental and behavioural disorders
0.000 0.995 0.005
K22.7 Barrett's oesophagus
0.005 0.995 0.000
F18 Mental and behavioural disorders due to use of volatile solvents
0.000 0.995 0.005
F16 Mental and behavioural disorders due to use of hallucinogens
0.000 0.995 0.005
F15 Mental and behavioural disorders due to use of other stimulants, including caffeine
0.000 0.995 0.005
F14 Mental and behavioural disorders due to use of cocaine
0.000 0.995 0.005
F13 Mental and behavioural disorders due to use of sedatives or hypnotics
0.000 0.995 0.005
F31 Bipolar affective disorder
0.000 0.995 0.005
N18.9 Chronic renal failure, unspecified
0.005 0.995 0.000
Y90-Y98 Supplementary factors related to causes of morbidity and mortality classified elsewhere
0.005 0.995 0.000
M79.67 Pain in limb (Ankle and foot)
0.005 0.995 0.000
K60.4 Rectal fistula
0.005 0.995 0.000
S01.5 Open wound of lip and oral cavity
0.000 0.995 0.005
F19 Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances
0.000 0.995 0.005
F50-F59 Behavioural syndromes associated with physiological disturbances and physical factors
0.000 0.995 0.005
R47.8 Other and unspecified speech disturbances
0.000 0.995 0.005
D69 Purpura and other haemorrhagic conditions
0.005 0.995 0.000
D04.6 Skin of upper limb, including shoulder
0.005 0.995 0.000
N17 Acute renal failure
0.005 0.995 0.000
F12 Mental and behavioural disorders due to use of cannabinoids
0.000 0.995 0.005
F11 Mental and behavioural disorders due to use of opioids
0.000 0.995 0.004
I30.9 Acute pericarditis, unspecified
0.000 0.995 0.005
F31.6 Bipolar affective disorder, current episode mixed
0.000 0.995 0.004
F31.4 Bipolar affective disorder, current episode severe depression without psychotic symptoms
0.000 0.995 0.004
K60.2 Anal fissure, unspecified
0.005 0.995 0.000
F52 Sexual dysfunction, not caused by organic disorder or disease
0.000 0.995 0.004
F33.0 Recurrent depressive disorder, current episode mild
0.000 0.996 0.004
N18.2 Chronic kidney disease, stage 2
0.004 0.996 0.000
F52.2 Failure of genital response
0.000 0.996 0.004
O75.2 Pyrexia during labour, not elsewhere classified
0.004 0.996 0.000
F32 Depressive episode
0.000 0.996 0.004
F80-F89 Disorders of psychological development
0.000 0.996 0.004
O68.9 Labour and delivery complicated by foetal stress, unspecified
0.004 0.996 0.000
F32.1 Moderate depressive episode
0.000 0.996 0.004
F34 Persistent mood [affective] disorders
0.000 0.996 0.004
F32.2 Severe depressive episode without psychotic symptoms
0.000 0.996 0.004
Y91 Evidence of alcohol involvement determined by level of intoxication
0.004 0.996 0.000
F33.8 Other recurrent depressive disorders
0.000 0.996 0.004
F33.4 Recurrent depressive disorder, currently in remission
0.000 0.996 0.004
O68 Labour and delivery complicated by foetal stress [distress]
0.004 0.996 0.000
F31.0 Bipolar affective disorder, current episode hypomanic
0.000 0.996 0.004
K90.0 Coeliac disease
0.004 0.996 0.000
T51 Toxic effect of alcohol
0.000 0.996 0.004
F31.5 Bipolar affective disorder, current episode severe depression with psychotic symptoms
0.000 0.996 0.004
F38 Other mood [affective] disorders
0.000 0.996 0.004
G82.2 Paraplegia, unspecified
0.004 0.996 0.000
Y90 Evidence of alcohol involvement determined by blood alcohol level
0.004 0.996 0.000
D69.2 Other nonthrombocytopenic purpura
0.004 0.996 0.000
F31.1 Bipolar affective disorder, current episode manic without psychotic symptoms
0.000 0.996 0.004
F90-F98 Behavioural and emotional disorders with onset usually occurring in childhood and adolescence
0.000 0.996 0.004
F33.3 Recurrent depressive disorder, current episode severe with psychotic symptoms
0.000 0.996 0.004
F31.2 Bipolar affective disorder, current episode manic with psychotic symptoms
0.000 0.996 0.004
F13.9 Unspecified mental and behavioural disorder
0.000 0.996 0.004
F13.8 Other mental and behavioural disorders
0.000 0.996 0.004
F13.7 Residual and late-onset psychotic disorder
0.000 0.996 0.004
F13.6 Amnesic syndrome
0.000 0.996 0.004
F13.5 Psychotic disorder
0.000 0.996 0.004
F13.4 Withdrawal state with delirium
0.000 0.996 0.004
F13.3 Withdrawal state
0.000 0.996 0.004
F13.2 Dependence syndrome
0.000 0.996 0.004
F13.1 Harmful use
0.000 0.996 0.004
F13.0 Acute intoxication
0.000 0.996 0.004
F14.9 Unspecified mental and behavioural disorder
0.000 0.996 0.004
F14.8 Other mental and behavioural disorders
0.000 0.996 0.004
F14.7 Residual and late-onset psychotic disorder
0.000 0.996 0.004
F14.6 Amnesic syndrome
0.000 0.996 0.004
F14.5 Psychotic disorder
0.000 0.996 0.004
F14.4 Withdrawal state with delirium
0.000 0.996 0.004
F14.3 Withdrawal state
0.000 0.996 0.004
F14.2 Dependence syndrome
0.000 0.996 0.004
F14.1 Harmful use
0.000 0.996 0.004
F14.0 Acute intoxication
0.000 0.996 0.004
F15.9 Unspecified mental and behavioural disorder
0.000 0.996 0.004
F15.8 Other mental and behavioural disorders
0.000 0.996 0.004
F15.7 Residual and late-onset psychotic disorder
0.000 0.996 0.004
F15.6 Amnesic syndrome
0.000 0.996 0.004
F15.5 Psychotic disorder
0.000 0.996 0.004
F15.4 Withdrawal state with delirium
0.000 0.996 0.004
F15.3 Withdrawal state
0.000 0.996 0.004
F15.2 Dependence syndrome
0.000 0.996 0.004
F15.1 Harmful use
0.000 0.996 0.004
F15.0 Acute intoxication
0.000 0.996 0.004
F16.9 Unspecified mental and behavioural disorder
0.000 0.996 0.004
F16.8 Other mental and behavioural disorders
0.000 0.996 0.004
F16.7 Residual and late-onset psychotic disorder
0.000 0.996 0.004
F16.6 Amnesic syndrome
0.000 0.996 0.004
F16.5 Psychotic disorder
0.000 0.996 0.004
F16.4 Withdrawal state with delirium
0.000 0.996 0.004
F16.3 Withdrawal state
0.000 0.996 0.004
F16.2 Dependence syndrome
0.000 0.996 0.004
F16.1 Harmful use
0.000 0.996 0.004
F16.0 Acute intoxication
0.000 0.996 0.004
F18.9 Unspecified mental and behavioural disorder
0.000 0.996 0.004
F18.8 Other mental and behavioural disorders
0.000 0.996 0.004
F18.7 Residual and late-onset psychotic disorder
0.000 0.996 0.004
F18.6 Amnesic syndrome
0.000 0.996 0.004
F18.5 Psychotic disorder
0.000 0.996 0.004
F18.4 Withdrawal state with delirium
0.000 0.996 0.004
F18.3 Withdrawal state
0.000 0.996 0.004
F18.2 Dependence syndrome
0.000 0.996 0.004
F18.1 Harmful use
0.000 0.996 0.004
F18.0 Acute intoxication
0.000 0.996 0.004
F31.8 Other bipolar affective disorders
0.000 0.996 0.004
F31.3 Bipolar affective disorder, current episode mild or moderate depression
0.000 0.996 0.004
L40.5 Arthropathic psoriasis
0.004 0.996 0.000
F70-F79 Mental retardation
0.000 0.996 0.004
F50 Eating disorders
0.000 0.996 0.004
Y98 Lifestyle-related condition
0.004 0.996 0.000
Y97 Environmental-pollution-related condition
0.004 0.996 0.000
Y96 Work-related condition
0.004 0.996 0.000
F60-F69 Disorders of adult personality and behaviour
0.000 0.996 0.004
M79.6 Pain in limb
0.004 0.996 0.000
F19.9 Unspecified mental and behavioural disorder
0.000 0.996 0.003
F19.8 Other mental and behavioural disorders
0.000 0.996 0.003
F19.7 Residual and late-onset psychotic disorder
0.000 0.996 0.003
F19.6 Amnesic syndrome
0.000 0.996 0.003
F19.5 Psychotic disorder
0.000 0.996 0.003
F19.4 Withdrawal state with delirium
0.000 0.996 0.003
F19.3 Withdrawal state
0.000 0.996 0.003
F19.2 Dependence syndrome
0.000 0.996 0.003
F19.0 Acute intoxication
0.000 0.996 0.003
Y91.9 Alcohol involvement, not otherwise specified
0.004 0.996 0.000
F53 Mental and behavioural disorders associated with the puerperium, not elsewhere classified
0.000 0.996 0.004
F51 Nonorganic sleep disorders
0.000 0.996 0.004
F59 Unspecified behavioural syndromes associated with physiological disturbances and physical factors
0.000 0.996 0.004
F55 Abuse of non-dependence-producing substances
0.000 0.996 0.004
F54 Psychological and behavioural factors associated with disorders or diseases classified elsewhere
0.000 0.996 0.004
D69.8 Other specified haemorrhagic conditions
0.004 0.996 0.000
D69.1 Qualitative platelet defects
0.004 0.996 0.000
N17.0 Acute renal failure with tubular necrosis
0.004 0.996 0.000
F10.1 Harmful use
0.000 0.996 0.004
Z34 Supervision of normal pregnancy
0.004 0.996 0.000
D69.4 Other primary thrombocytopenia
0.004 0.996 0.000
N17.8 Other acute renal failure
0.004 0.996 0.000
N17.2 Acute renal failure with medullary necrosis
0.004 0.996 0.000
N17.1 Acute renal failure with acute cortical necrosis
0.004 0.996 0.000
F84 Pervasive developmental disorders
0.000 0.996 0.004
F32.0 Mild depressive episode
0.000 0.996 0.004
F11.9 Unspecified mental and behavioural disorder
0.000 0.996 0.003
F11.8 Other mental and behavioural disorders
0.000 0.996 0.003
F11.7 Residual and late-onset psychotic disorder
0.000 0.996 0.003
F11.6 Amnesic syndrome
0.000 0.996 0.003
F11.5 Psychotic disorder
0.000 0.996 0.003
F11.4 Withdrawal state with delirium
0.000 0.996 0.003
F11.3 Withdrawal state
0.000 0.996 0.003
F11.0 Acute intoxication
0.000 0.996 0.003
F12.9 Unspecified mental and behavioural disorder
0.000 0.996 0.003
F12.8 Other mental and behavioural disorders
0.000 0.996 0.003
F12.7 Residual and late-onset psychotic disorder
0.000 0.996 0.003
F12.6 Amnesic syndrome
0.000 0.996 0.003
F12.5 Psychotic disorder
0.000 0.996 0.003
F12.4 Withdrawal state with delirium
0.000 0.996 0.003
F12.3 Withdrawal state
0.000 0.996 0.003
F12.0 Acute intoxication
0.000 0.996 0.003
M79.66 Pain in limb (Lower leg)
0.004 0.996 0.000
F39 Unspecified mood [affective] disorder
0.000 0.996 0.003
F52.9 Unspecified sexual dysfunction, not caused by organic disorder or disease
0.000 0.996 0.003
F52.8 Other sexual dysfunction, not caused by organic disorder or disease
0.000 0.996 0.003
F52.7 Excessive sexual drive
0.000 0.996 0.003
F52.6 Nonorganic dyspareunia
0.000 0.996 0.003
F52.5 Nonorganic vaginismus
0.000 0.996 0.003
F52.4 Premature ejaculation
0.000 0.996 0.003
F52.3 Orgasmic dysfunction
0.000 0.996 0.003
F52.1 Sexual aversion and lack of sexual enjoyment
0.000 0.996 0.003
F52.0 Lack or loss of sexual desire
0.000 0.996 0.003
F34.1 Dysthymia
0.000 0.996 0.003
F81 Specific developmental disorders of scholastic skills
0.000 0.996 0.003
F19.1 Harmful use
0.000 0.997 0.003
F12.2 Dependence syndrome
0.000 0.997 0.003
D69.5 Secondary thrombocytopenia
0.003 0.997 0.000
F31.9 Bipolar affective disorder, unspecified
0.000 0.997 0.003
Y90.8 Blood alcohol level of 240 mg/100 ml or more
0.003 0.997 0.000
F89 Unspecified disorder of psychological development
0.000 0.997 0.003
F88 Other disorders of psychological development
0.000 0.997 0.003

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2024 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.